DÄ internationalArchiveReferences
References

cme

Red Eye: A Guide for Non-specialists

Dtsch Arztebl Int 2017; 114: 302-12. DOI: 10.3238/arztebl.2017.0302

Frings, A; Geerling, G; Schargus, M

1.Pflipsen M, Massaquoi M, Wolf S: Evaluation of the painful eye. Am Fam Physician 2016; 93: 991–8 MEDLINE
2.Teo MA: Improving acute eye consultations in general practice: a practical approach. BMJ Qual Improv Rep. 2014; 3: pii: u206617.w2852.
3.Cronau H, Kankanala RR, Mauger T: Diagnosis and management of red eye in primary care. Am Fam Physician 2010; 81: 137–44 MEDLINE
4.Statham MO, Sharma A, Pane AR: Misdiagnosis of acute eye diseases by primary health care providers: incidence and implications. Med J Aust 2008; 189: 402–4 MEDLINE
5.O‘Connor PM, Crock CT, Dhillon RS, Keeffe JE: Resources for the management of ocular emergencies in Australia. Emerg Med Australas 2011; 23: 331–6 CrossRef MEDLINE
6.Azari AA, Barney NP: Conjunctivitis: a systematic review of diagnosis and treatment. JAMA 2013; 310: 1721–9 CrossRef MEDLINE PubMed Central
7.Abelson MB, Butrus SI, Weston JH, Rosner B: Tolerance and absence of rebound vasodilation following topical ocular decongestant usage. Ophthalmology 1984; 91: 1364–7 CrossRef
8.Alfonso SA, Fawley JD, Alexa Lu X: Conjunctivitis. Prim Care 2015; 42: 325–45 CrossRef MEDLINE
9.Messmer EM: Keratitis—infectious or autoimmune? Klin Monbl Augenheilkd 2016; 233: 808–12 CrossRef MEDLINE
10.Fernandes M, Vira D, Medikonda R, Kumar N: Extensively and pan-drug resistant pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome. Graefes Arch Clin Exp Ophthalmol 2016; 254: 315–22 CrossRef MEDLINE
11.Vazirani J, Wurity S, Ali MH: Multidrug-resistant pseudomonas aeruginosa keratitis: risk factors, clinical characteristics, and outcomes. Ophthalmology 2015; 122: 2110–4 CrossRef MEDLINE
12.Tsatsos M, MacGregor C, Athanasiadis I, Moschos MM, Hossain P, Anderson D: Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clin Experiment Ophthalmol 2016; 44: 824–37 CrossRef MEDLINE
13.Adhikary AK, Banik U: Human adenovirus type 8: the major agent of epidemic keratoconjunctivitis (EKC). J Clin Virol 2014; 61: 477–86 CrossRef MEDLINE
14.Jhanji V, Chan TC, Li EY, Agarwal K, Vajpayee RB: Adenoviral keratoconjunctivitis. Surv Ophthalmol 2015; 60: 435–43 CrossRef MEDLINE
15.Meyer-Rüsenberg B, Loderstädt U, Richard G, Kaulfers PM, Gesser C: Epidemic keratoconjunctivitis—the current situation and recommendations for prevention and treatment. Dtsch Arztebl Int 2011; 108: 475–80 VOLLTEXT
16.Chi JJ: Management of the eye in facial paralysis. Facial Plast Surg Clin North Am 2016; 24: 21–8 CrossRef MEDLINE
17.Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A: Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Cochrane Database Syst Rev 2015; 6: CD009566 CrossRef
18.Schröder K, Finis D, Meller S, Buhren BA, Wagenmann M, Geerling G: Seasonal and perennial allergic rhinoconjunctivitis. Klin Monbl Augenheilkd 2014; 231: 496–504 CrossRef MEDLINE
19.Messmer EM: Ocular allergies. Ophthalmologe 2005; 102: 527–43 CrossRef MEDLINE
20.Messmer EM: The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int 2015; 112: 71–81 VOLLTEXT
21.Roth S, Thisted RA, Erickson JP, Black S, Schreider BD: Eye injuries after nonocular surgery. A study of 60,965 anesthetics from 1988 to 1992. Anesthesiology 1996; 85: 1020–7 CrossRef MEDLINE
22.Sobolewska B, Zierhut M: Episkleritis und Skleritis. Augenheilkunde up2date 2015; 5: 51–62 CrossRef
23.Diaz JD, Sobol EK, Gritz DC: Treatment and management of scleral disorders. Surv Ophthalmol 2016; 61: 702–17 CrossRef MEDLINE
24.Dunn JP: Uveitis. Prim Care 2015; 42: 305–23 CrossRef MEDLINE
25.Silpa-Archa S, Oray M, Preble JM, Foster CS: Outcome of tocilizumab treatment in refractory ocular inflammatory diseases. Acta Ophthalmol 2016; 94: e400–6 CrossRef MEDLINE
26.Suhler EB, Lim LL, Beardsley RM, et al.: Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial. Ophthalmology 2014; 121: 1885–91 CrossRef MEDLINE
27.D‘Ambrosio EM, Cava M, Tortorella P, Gharbyia M, Campanella M, Iannetti L: Clinical features and complications of the HLA-B27-associated acute anterior uveitis: a metanalysis. Semin Ophthalmol 2016; 12: 1–13 CrossRef MEDLINE
28.Pathanapitoon K, Dodds EM, Cunningham ET Jr, Rothova A: Clinical spectrum of HLA-B27-associated ocular inflammation. Ocul Immunol Inflamm 2016; 18: 1–8 CrossRef CrossRef MEDLINE
29.Stavropoulos PG, Soura E, Kanelleas A, Katsambas A, Antoniou C: Reactive arthritis. J Eur Acad Dermatol Venereol 2015; 29: 415–24 CrossRef MEDLINE
30.Heiligenhaus A, Minden K, Föll D, Pleyer U: Uveitis in juvenile idiopathic arthritis. Dtsch Arztebl Int 2015; 112: 92–100 VOLLTEXT
31.Wright C, Tawfik MA, Waisbourd M, Katz LJ: Primary angle-closure glaucoma: an update. Acta Ophthalmol 2016; 94: 217–25 CrossRef MEDLINE
32.Schwenn O: Acute angle closure, chronic angle-closure glaucoma and their differential diagnoses. Klin Monbl Augenheilkd 2011; 228: 95–104 CrossRef MEDLINE
33.Carlisle RT, Digiovanni J: Differential diagnosis of the swollen red eyelid. Am Fam Physician 2015; 92: 106–12 MEDLINE
34.Lindsley K, Nichols JJ, Dickersin K: Interventions for acute internal hordeolum. Cochrane Database Syst Rev 2013: CD007742 CrossRef
35.Press UP: The aging eyelid. Klin Monbl Augenheilkd 2010; 227: 15–9 CrossRef MEDLINE
36.Gonzalez Castro LN, Colorado RA, Botelho AA, Freitag SK, Rabinov JD, Silverman SB: Carotid-cavernous fistula: a rare but treatable cause of rapidly progressive vision loss. Stroke 2016; 47: 207–9 CrossRef MEDLINE
37.Nivenius E, Montan P: Spontaneous corneal perforation associated with atopic keratoconjunctivitis: a case series and literature review. Acta Ophthalmol 2015; 93: 383–7 CrossRef MEDLINE
e1.Behrens-Baumann W, Quentin CD, Gibson JR, Calthrop JG, Harvey SG, Booth K: Trimethoprim-polymyxin B sulphate ophthalmic ointment in the treatment of bacterial conjunctivitis: a double-blind study versus chloramphenicol ophthalmic ointment. Curr Med Res Opin 1988; 11: 227–31 CrossRef MEDLINE
e2.Jauch A, Fsadni M, Gamba G: Meta-analysis of six clinical phase III studies comparing iomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis. Graefes Arch Clin Exp Ophthalmol 1999; 237: 705–13 CrossRef MEDLINE
e3.Lohr JA, Austin RD, Grossman M, Hayden GF, Knowlton GM, Dudley SM: Comparison of three topical antimicrobials for acute bacterial conjunctivitis. Pediatr Infect Dis J 1988; 7: 626–9 CrossRef
e4.Protzko E, Bowman L, Abelson M, Shapiro A: Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis. Invest Ophthalmol Vis Sci 2007; 48: 3425–9 CrossRef MEDLINE
e5.Messmer EM: Keratitis—infectious or autoimmune? Klin Monbl Augenheilkd 2016; 233: 808–12 MEDLINE
e6.Robert Koch-Institut: Adenovirus-Konjunktivitis: RKI-Ratgeber für Ärzte. www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Adenovirus_Konjunktivitis.html#doc2393452bodyText16 (last accessed on 3 January 2017).
e7.Tsatsos M, MacGregor C, Athanasiadis I, Moschos MM, Hossain P, Anderson D: Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clin Exp Ophthalmol 2016: 44: 824–37. doi: 10.1111/ceo.1278 CrossRef
e8.Wilhelmus KR: Interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev 2003; 3: CD002898. Update in: Cochrane Database Syst Rev 2007; 1: CD002898.
e9.Vrcek I, Choudhury E, Durairaj V: Herpes zoster ophthalmicus: a review for the internist. Am J Med 2017, 130: 21–6 CrossRef MEDLINE
e10.Schuster AK, Harder BC, Schlichtenbrede FC, Jarczok MN, Tesarz J: Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. Cochrane Database Syst Rev 2016; 11: CD011503 MEDLINE
e11.Sacchetti M, Lambiase A: Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol 2014; 8: 571–9 MEDLINE PubMed Central
e12.Yanai R, Nishida T, Chikama T, Morishige N, Yamada N, Sonoda KH: Potential new modes of treatment of neurotrophic keratopathy. Cornea 2015; 34: 121–7 CrossRef MEDLINE
e13.Kam KW, Chen LJ, Wat N, Young AL: Topical olopatadine in the treatment of allergic conjunctivitis: a systematic review and meta-analysis. Ocul Immunol Inflamm 2016; 18: 1–15.
e14.Wang TJ, Keller JJ, Sheu JJ, Lin HC: A 3-year follow-up study on the risk of stroke among patients with conjunctival haemorrhage. Acta Ophthalmol 2013; 91: 226–30 CrossRef MEDLINE
e15.Barequet IS, Harizman N, Ziv H, Rosner M: Healing rate of corneal erosions: comparison of the effect of chloramphenicol eye drops and ointment and high-concentration hyaluronic acid in an animal model. Cornea 2014; 33: 1080–2 CrossRef MEDLINE
e16.Cullen AP: Photokeratitis and other phototoxic effects on the cornea and conjunctiva. Int J Toxicol 2002; 21: 455–64 CrossRef MEDLINE
e17.Ting MA, Saha K, Robbie S: Mass photokeratitis following ultraviolet light exposure at a nightclub. Cont Lens Anterior Eye 2016; 39: 316–7 CrossRef MEDLINE
e18.Tappeiner C, Walscheid K, Heiligenhaus A: Diagnosis and treatment of episcleritis and scleritis. Ophthalmologe 2016; 113: 797–810 MEDLINE
e19.Daniel Diaz J, Sobol EK, Gritz DC: Treatment and management of scleral disorders. Surv Ophthalmol 2016; 61: 702–17 CrossRef MEDLINE
e20.Cocho L, Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Sainz-de-la-Maza M, Foster CS: Scleritis in patients with granulomatosis with polyangiitis (Wegener). Br J Ophthalmol 2016; 100: 1062–5 CrossRef MEDLINE
e21.Generali E, Cantarini L, Selmi C: Ocular involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol 2015; 49: 263–70 CrossRef MEDLINE
e22.Foster CS, Forstot SL, Wilson LA: Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology 1984; 91: 1253–63 CrossRef
e23.Jaffe GJ, Dick AD, Brézin AP, et al.: Adalimumab in patients with active noninfectious uveitis. N Engl J Med 2016; 375: 932–43 CrossRef MEDLINE
e24.Thurau S, Pleyer U: Differential diagnosis of anterior uveitis. Ophthalmologe 2016; 113: 879–92 MEDLINE
e25.Wright C, Tawfik MA, Waisbourd M, Katz LJ: Primary angle-closure glaucoma: an update. Acta Ophthalmol 2016; 94: 217–25 CrossRef MEDLINE
e26.Liebmann JM, Ritch R: Laser surgery for angle closure glaucoma. Semin Ophthalmol 2002; 17: 84–91 CrossRef MEDLINE